|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Atara Biotherapeutics, Inc. (ATRA) |
|
|
$0.39 0.00 (0.00%) as of 4:30 Tue 6/18
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
108,674,000 |
| Market
Cap: |
42.88(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2298 - $2.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 707 |
| Guru Rank Value : 1.9 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
816,825 |
816,825 |
| Total Buy Value |
$0 |
$0 |
$194,885 |
$194,885 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
4 |
4 |
| Total Shares Sold |
211,204 |
267,396 |
419,842 |
591,605 |
| Total Sell Value |
$130,313 |
$170,773 |
$340,560 |
$980,941 |
| Total People Sold |
5 |
5 |
6 |
9 |
| Total Sell Transactions |
5 |
10 |
23 |
41 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2016-04-11 |
4 |
AS |
$20.42 |
$245,244 |
I/I |
(12,010) |
366,011 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2016-04-01 |
4 |
AS |
$20.04 |
$17,836 |
I/I |
(890) |
378,021 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2016-03-31 |
4 |
AS |
$20.01 |
$6,003 |
I/I |
(300) |
378,911 |
|
- |
|
| Dobmeier Eric |
Director |
– • – |
2016-03-17 |
4 |
B |
$13.86 |
$41,565 |
D/D |
3,000 |
5,500 |
2.39 |
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2016-02-17 |
4 |
AS |
$16.30 |
$19,283 |
D/D |
(1,183) |
94,280 |
|
- |
|
| Soffer Gad |
Chief Operating Officer |
• – – |
2016-02-17 |
4 |
AS |
$16.07 |
$95,786 |
D/D |
(5,711) |
128,510 |
|
- |
|
| Gallagher Carol Giltner |
Director |
– • – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,365 |
95,463 |
|
- |
|
| Fust Matthew K |
Director |
– • – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,603 |
12,286 |
|
- |
|
| Soffer Gad |
Chief Operating Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,761 |
134,221 |
|
- |
|
| Clark Mitchall G. |
Chief R & QA Officer |
• – – |
2016-02-16 |
4 |
AS |
$15.35 |
$63,749 |
D/D |
(4,153) |
80,700 |
|
- |
|
| Clark Mitchall G. |
Chief R & QA Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,211 |
84,853 |
|
- |
|
| Haqq Christopher |
Chief Medical Officer |
• – – |
2016-02-16 |
4 |
AS |
$15.43 |
$49,499 |
D/D |
(3,208) |
295,240 |
|
- |
|
| Haqq Christopher |
Chief Medical Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
829 |
298,448 |
|
- |
|
| Mcgrath John |
Chief Financial Officer |
• – – |
2016-02-16 |
4 |
AS |
$15.49 |
$92,940 |
D/D |
(6,000) |
83,714 |
|
- |
|
| Mcgrath John |
Chief Financial Officer |
• – – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,501 |
89,714 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2016-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,908 |
217,321 |
|
- |
|
| Haqq Christopher |
Chief Medical Officer |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
55,900 |
297,619 |
|
- |
|
| Turner Heather D |
VP, General Counsel & Sec. |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
48,857 |
48,857 |
|
- |
|
| Mcgrath John |
Chief Financial Officer |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
42,857 |
79,213 |
|
- |
|
| Soffer Gad |
Chief Operating Officer |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
48,447 |
120,460 |
|
- |
|
| Clark Mitchall G. |
Chief R & QA Officer |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
42,857 |
77,642 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
163,973 |
211,413 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2016-01-14 |
4 |
AS |
$20.07 |
$24,084 |
I/I |
(1,200) |
379,211 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2016-01-13 |
4 |
AS |
$20.32 |
$24,384 |
I/I |
(1,200) |
380,411 |
|
- |
|
| Ciechanover Isaac E. |
Chief Executive Officer |
• • – |
2015-12-31 |
4 |
AS |
$26.00 |
$32,136 |
I/I |
(1,200) |
381,611 |
|
- |
|
736 Records found
|
|
Page 25 of 30 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
